Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
Title:
Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
Author:
Schwedt, Todd J. Myers Oakes, Tina M. Martinez, James M. Vargas, Bert B. Pandey, Hitendra Pearlman, Eric M. Richardson, Diane R. Varnado, Oralee J. Cobas Meyer, Michael Goadsby, Peter J.